Re: Farmas USA
SGYP
Se empieza a calentar para su cita para nuevas apliaciones de su ya aprobado y en el mercado medicamento TRULANCE
En grafico diaro empieza a hacer Golden Cross MME20/MME50 y el MACD ha despegar
2da vela alcista hoy
--
H.C. Wainwright analyst Ram Selvaraju likes the shift in leadership, and believes both this and the forthcoming date with destiny for Trulance’s supplemental New Drug Application (sNDA) in constipation-predominant irritable bowel syndrome (IBS-C) come January 24th will prove to also “spur interest” as a short-term “regulatory catalyst.”
--
Alguna otra opinion por aqui